Olink Holding AB (publ) (OLK) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in Uppsala, Sweden. The current CEO is Jon Heimer.
OLK has IPO date of 2021-03-26, 707 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $3.24B.
Olink Holding AB (publ) is a Swedish life sciences company founded in 2004 and headquartered in Uppsala that provides protein analysis products and services to academic institutions, government agencies, and biopharmaceutical and biotechnology companies. The company's platform includes Olink Explore for disease-specific research areas such as cardiovascular, metabolic, oncology, and neurology applications, along with customizable Olink Target and Olink Focus product lines. Olink offers comprehensive solutions spanning assay execution through its Olink Signature Q100 platform, analytical services including study design and data processing, and software tools such as NPX Manager and Olink Insight for data visualization and statistical analysis. The company operates a direct sales organization across the Americas, Europe, the Middle East, Africa, and Asia Pacific regions to serve its global customer base.
